View Archive »
About The Cover
Analysis of CST5 expression and localization in SW480/pRTR-p53-VSV cells by confocal immunofluorescence microscopy after 48 hours with and without DOX treatment. See Hünten et al.
|
|
Table of Contents
Editorial
|
| Crosstalk of parkin and Ret in dopaminergic neurons |
|
https://doi.org/10.18632/oncotarget.4465
|
| 15704-15705 |
|
| IP3 3kinase B prevents bone marrow failure |
|
https://doi.org/10.18632/oncotarget.4480
|
| 15706-15707 |
|
| Networking in metabolism and human disease |
|
https://doi.org/10.18632/oncotarget.4561
|
| 15708-15709 |
|
| MEL18 a tumor suppressor for aggressive breast cancer |
|
https://doi.org/10.18632/oncotarget.4565
|
| 15710-15711 |
|
| IER3 in pancreatic carcinogenesis |
|
https://doi.org/10.18632/oncotarget.4588
|
| 15712-15713 |
|
| Sexual selection and cancer biology |
|
https://doi.org/10.18632/oncotarget.4592
|
| 15714-15715 |
|
| Radiation holidays stimulate tumor immunity |
|
https://doi.org/10.18632/oncotarget.4608
|
| 15716-15717 |
|
| Ubiquitin signals the demise of AMPA receptors |
|
https://doi.org/10.18632/oncotarget.4645
|
| 15718-15719 |
|
| KLF 6: a mitochondrial regulator in the kidney |
|
https://doi.org/10.18632/oncotarget.4647
|
| 15720-15721 |
|
| Unleashing rapamycin in fibrosis |
|
https://doi.org/10.18632/oncotarget.4652
|
| 15722-15723 |
|
| Angiogenesis and bleeding disorders in FNAIT |
|
https://doi.org/10.18632/oncotarget.4757
|
| 15724-15725 |
|
| Holding it together: Naa60 at the Golgi |
|
https://doi.org/10.18632/oncotarget.4779
|
| 15726-15727 |
|
| Astrocytic TGFβ1: detrimental factor in ALS |
|
https://doi.org/10.18632/oncotarget.4786
|
| 15728-15729 |
Editorial: Chromosome
|
| Repair of chromosomal breaks by NHEJ |
|
https://doi.org/10.18632/oncotarget.4593
|
| 15730-15731 |
|
| SUMO in the DNA damage response |
|
https://doi.org/10.18632/oncotarget.4605
|
| 15734-15735 |
|
| Gatekeepers of pancreas: TEAD and YAP |
|
https://doi.org/10.18632/oncotarget.4607
|
| 15736-15737 |
|
| GWAS reveal novel IgA nephropathy risk loci |
|
https://doi.org/10.18632/oncotarget.4632
|
| 15738-15739 |
|
| Bidirectional talk between AhR and Oct4 |
|
https://doi.org/10.18632/oncotarget.4633
|
| 15740-15741 |
|
| Vimentin gets a new glow from zinc |
|
https://doi.org/10.18632/oncotarget.4649
|
| 15742-15743 |
|
| N6methyladenine: a potential epigenetic mark in eukaryotes |
|
https://doi.org/10.18632/oncotarget.4684
|
| 15744-15745 |
|
| A nuclear sensor of mitochondrial function |
|
https://doi.org/10.18632/oncotarget.4687
|
| 15746-15747 |
|
| Plant immune receptor decoy: Pathogens in their own trap |
|
https://doi.org/10.18632/oncotarget.4717
|
| 15748-15749 |
|
| Reproductive aging and MCM8/9 |
|
https://doi.org/10.18632/oncotarget.4589
|
| 15750-15751 |
Reviews
|
| Hematopoietic cell kinase HCK as a therapeutic target in immune and cancer cells |
|
https://doi.org/10.18632/oncotarget.4199
|
| 15752-15771 |
|
| Oncogenic cancer/testis antigens: prime candidates for immunotherapy |
|
https://doi.org/10.18632/oncotarget.4694
|
| 15772-15787 |
Priority Research Papers
|
| Selective impact of CDK4/6 suppression on patientderived models of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.3819
|
| 15788-15801 |
|
| p53 and rapamycin are additive |
|
https://doi.org/10.18632/oncotarget.4602
|
| 15802-15813 |
|
| A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.4538
|
| 15814-15827 |
|
| TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney |
|
https://doi.org/10.18632/oncotarget.4682
|
| 15828-15841 |
|
| p53 directly activates cystatin D/CST5 to mediate mesenchymalepithelial transition: a possible link to tumor suppression by vitamin D3 |
|
https://doi.org/10.18632/oncotarget.4683
|
| 15842-15856 |
|
| Structurally diverse cMyc inhibitors share a common mechanism of action involving ATP depletion |
|
https://doi.org/10.18632/oncotarget.4327
|
| 15857-15870 |
Research Papers: Pathology
|
| Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
|
https://doi.org/10.18632/oncotarget.3869
|
| 15871-15881 |
Research Papers: Gerotarget (Focus on Aging)
|
| Histone modifications change with age dietary restriction and rapamycin treatment in mouse brain |
|
https://doi.org/10.18632/oncotarget.4137
|
| 15882-15890 |
|
| Hypermaintenance and hypofunction of aged spermatogonia: insight from agerelated increase of Plzf expression |
|
https://doi.org/10.18632/oncotarget.4045
|
| 15891-15901 |
|
| The effects of graded levels of calorie restriction: I impact of short term calorie and protein restriction on body composition in the C57BL/6 mouse |
|
https://doi.org/10.18632/oncotarget.4142
|
| 15902-15930 |
Research Papers
|
| CpG oligodeoxynucleotide CpG685 upregulates functional interleukin21 receptor on chronic lymphocytic leukemia B cells through an NFκB mediated pathway |
|
https://doi.org/10.18632/oncotarget.3285
|
| 15931-15939 |
|
| Macrolide analog F806 suppresses esophageal squamous cell carcinoma ESCC by blocking β1 integrin activation |
|
https://doi.org/10.18632/oncotarget.3612
|
| 15940-15952 |
|
| Pregnancy associated plasma proteinA links pregnancy and melanoma progression by promoting cellular migration and invasion |
|
https://doi.org/10.18632/oncotarget.3643
|
| 15953-15965 |
|
| Vimentin contributes to epithelialmesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation |
|
https://doi.org/10.18632/oncotarget.3862
|
| 15966-15983 |
|
| Radiationinduced microRNA622 causes radioresistance in colorectal cancer cells by downregulating Rb |
|
https://doi.org/10.18632/oncotarget.3762
|
| 15984-15994 |
|
| miR504 mediated downregulation of nuclear respiratory factor 1 leads to radioresistance in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.4138
|
| 15995-16018 |
|
| Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain |
|
https://doi.org/10.18632/oncotarget.3496
|
| 16019-16030 |
|
| Tanshinone I inhibits tumor angiogenesis by reducing STAT3 phosphorylation at TYR705 and hypoxiainduced HIF1α accumulation in both endothelial and tumor cells |
|
https://doi.org/10.18632/oncotarget.3648
|
| 16031-16042 |
|
| MicroRNA155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1 |
|
https://doi.org/10.18632/oncotarget.3755
|
| 16043-16058 |
|
| Correlation between tumor engraftment in patientderived xenograft models and clinical outcomes in colorectal cancer patients |
|
https://doi.org/10.18632/oncotarget.3863
|
| 16059-16068 |
|
| Ca2+/calmodulindependent protein kinase IIγ enhances stemlike traits and tumorigenicity of lung cancer cells |
|
https://doi.org/10.18632/oncotarget.3866
|
| 16069-16083 |
|
| Novel cross talk between IGFIR and DDR1 regulates IGFIR trafficking signaling and biological responses |
|
https://doi.org/10.18632/oncotarget.3177
|
| 16084-16105 |
|
| Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas |
|
https://doi.org/10.18632/oncotarget.3867
|
| 16106-16119 |
|
| Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP13 production |
|
https://doi.org/10.18632/oncotarget.3878
|
| 16120-16134 |
|
| Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome |
|
https://doi.org/10.18632/oncotarget.3873
|
| 16135-16150 |
|
| Recombinant human alpha fetoprotein synergistically potentiates the anticancer effects of 1’S1’acetoxychavicol acetate when used as a complex against human tumours harbouring AFPreceptors |
|
https://doi.org/10.18632/oncotarget.3951
|
| 16151-16167 |
|
| Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer |
|
https://doi.org/10.18632/oncotarget.3753
|
| 16168-16182 |
|
| Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells |
|
https://doi.org/10.18632/oncotarget.3952
|
| 16183-16197 |
|
| Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammationassociated colorectal tumor |
|
https://doi.org/10.18632/oncotarget.3838
|
| 16198-16214 |
|
| MET expression and copy number heterogeneity in nonsquamous nonsmall cell lung cancer nsNSCLC |
|
https://doi.org/10.18632/oncotarget.3976
|
| 16215-16226 |
|
| miR15b5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma both in vitro and in vivo by suppressing Rab1A |
|
https://doi.org/10.18632/oncotarget.3970
|
| 16227-16238 |
|
| ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer |
|
https://doi.org/10.18632/oncotarget.3842
|
| 16239-16252 |
|
| Hepatomaderived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis |
|
https://doi.org/10.18632/oncotarget.3608
|
| 16253-16270 |
|
| Phosphorylation of interleukin IL24 is required for mediating its anticancer activity |
|
https://doi.org/10.18632/oncotarget.3977
|
| 16271-16286 |
|
| Ubiquitin Cterminal hydrolaseL1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4 |
|
https://doi.org/10.18632/oncotarget.3843
|
| 16287-16303 |
|
| Vitamin D3dependent VDR signaling delays ronmediated breast tumorigenesis through suppression of βcatenin activity |
|
https://doi.org/10.18632/oncotarget.4059
|
| 16304-16320 |
|
| Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation migration and invasion |
|
https://doi.org/10.18632/oncotarget.3872
|
| 16321-16340 |
|
| Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.3854
|
| 16341-16351 |
|
| Loss of RAB1B promotes triplenegative breast cancer metastasis by activating TGFβ/SMAD signaling |
|
https://doi.org/10.18632/oncotarget.3877
|
| 16352-16365 |
|
| PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest |
|
https://doi.org/10.18632/oncotarget.3879
|
| 16366-16378 |
|
| Polyphenolrich extract of Pimenta dioica berries Allspice kills breast cancer cells by autophagy and delays growth of triple negative breast cancer in athymic mice |
|
https://doi.org/10.18632/oncotarget.3834
|
| 16379-16395 |
|
| Honokiol abrogates leptininduced tumor progression by inhibiting Wnt1MTA1βcatenin signaling axis in a microRNA34a dependent manner |
|
https://doi.org/10.18632/oncotarget.3844
|
| 16396-16410 |
|
| Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer |
|
https://doi.org/10.18632/oncotarget.3845
|
| 16411-16421 |
|
| Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling |
|
https://doi.org/10.18632/oncotarget.3847
|
| 16422-16436 |
|
| Accumulation of ALDH1positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.4103
|
| 16437-16448 |
|
| SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: wholegenome analysis in patients with hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3758
|
| 16449-16460 |
|
| By recruiting HDAC1 MORC2 suppresses p21 Waf1/Cip1 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.3889
|
| 16461-16470 |
|
| Neutrophils trigger a NFκB dependent polarization of tumorsupportive stromal cells in germinal center Bcell lymphomas |
|
https://doi.org/10.18632/oncotarget.4106
|
| 16471-16487 |
|
| Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells |
|
https://doi.org/10.18632/oncotarget.4108
|
| 16488-16506 |
|
| Nuclear EGFR impairs ASPP2p53 complexinduced apoptosis by inducing SOS1 expression in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3757
|
| 16507-16516 |
|
| Increased cathepsin D protein expression is a biomarker for osteosarcomas pulmonary metastases and other bone malignancies |
|
https://doi.org/10.18632/oncotarget.4140
|
| 16517-16526 |
|
| A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.4113
|
| 16527-16542 |
|
| ATRX represses alternative lengthening of telomeres |
|
https://doi.org/10.18632/oncotarget.3846
|
| 16543-16558 |
|
| Notch signaling sustains the expression of Mcl1 and the activity of eIF4E to promote cell survival in CLL |
|
https://doi.org/10.18632/oncotarget.4116
|
| 16559-16572 |
|
| Estrogenic gper signaling regulates mir144 expression in cancer cells and cancerassociated fibroblasts cafs |
|
https://doi.org/10.18632/oncotarget.4117
|
| 16573-16587 |
|
| Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion |
|
https://doi.org/10.18632/oncotarget.3752
|
| 16588-16600 |
|
| 111Incetuximab as a diagnostic agent by accessible epidermal growth factor EGF receptor targeting in human metastatic colorectal carcinoma |
|
https://doi.org/10.18632/oncotarget.3968
|
| 16601-16610 |
|
| ERG deregulation induces IGF1R expression in prostate cancer cells and affects sensitivity to antiIGF1R agents |
|
https://doi.org/10.18632/oncotarget.3425
|
| 16611-16622 |
|
| Mcl1 is an important therapeutic target for oral squamous cell carcinomas |
|
https://doi.org/10.18632/oncotarget.3932
|
| 16623-16637 |
|
| Dual regulation by microRNA200b3p and microRNA200b5p in the inhibition of epithelialtomesenchymal transition in triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.3184
|
| 16638-16652 |
Clinical Research Papers
|
| Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients |
|
https://doi.org/10.18632/oncotarget.3914
|
| 16653-16662 |
|
| TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma |
|
https://doi.org/10.18632/oncotarget.4389
|
| 16663-16673 |
|
| Longitudinal study on circulating miRNAs in patients after lung cancer resection |
|
https://doi.org/10.18632/oncotarget.4322
|
| 16674-16685 |
|
| Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtype |
|
https://doi.org/10.18632/oncotarget.3647
|
| 16686-16697 |
|
| An openlabel singlearm phase I/II study of lowerdose decitabine based therapy in patients with advanced hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3677
|
| 16698-16711 |
|
| Immunohistochemical and genomic profiles of diffuse large Bcell lymphomas: Implications for targeted EZH2 inhibitor therapy |
|
https://doi.org/10.18632/oncotarget.3154
|
| 16712-16724 |
|
| Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases |
|
https://doi.org/10.18632/oncotarget.4264
|
| 16725-16734 |
|
| Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort |
|
https://doi.org/10.18632/oncotarget.3793
|
| 16735-16745 |
|
| Activation of insulinlike growth factor 1 receptor in patients with nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3796
|
| 16746-16756 |
|
| Six stromabased RNA markers diagnostic for prostate cancer in EuropeanAmericans validated at the RNA and protein levels in patients in China |
|
https://doi.org/10.18632/oncotarget.4430
|
| 16757-16765 |
|
| Distinctive clinical characteristics of malignant mesothelioma in young patients |
|
https://doi.org/10.18632/oncotarget.4414
|
| 16766-16773 |
|
| Highthroughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin |
|
https://doi.org/10.18632/oncotarget.3736
|
| 16774-16785 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
